Načítá se...
Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications
Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is asso...
Uloženo v:
| Vydáno v: | Neurohospitalist |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530424/ https://ncbi.nlm.nih.gov/pubmed/26288671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941874415587680 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|